IP Library Granted Patent US 11,147,919
Granted Patent B2
US 11,147,919 · App. 15/960,495 · Granted Oct 19, 2021

Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system

Inventors: Neha J. Parikh (West Hills, CA); Anirban Roy (Agoura Hills, CA); Benyamin Grosman (Valley Village, CA); Patrick E. Weydt (Moorpark, CA); Louis J. Lintereur (Stevenson Ranch, CA); Di Wu (Glendale, CA); Francine R. Kaufman (Los Angeles, CA); Scott W. Lee (Redlands, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61M5/172A61M5/1723G16H20/17A61M2205/50A61M2205/502A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,147,919
App. No.
15/960,495
Granted
Oct 19, 2021
Kind
B2
Abstract

Disclosed here is a computer-based device and related methodology that manages use of a dual-mode insulin infusion device. The infusion device operates in a manual insulin delivery mode or an automated closed-loop insulin delivery mode. The methodology receives closed-loop pump data for a user of the infusion device, the closed-loop pump data including data indicating basal insulin delivered by the infusion device during operation in the automated closed-loop insulin delivery mode for at least one defined period of time. The methodology analyzes the closed-loop pump data to generate updated basal rate data for the user, and generates, from the updated basal rate data, a recommendation to adjust a manual-mode basal rate setting of the infusion device. In certain scenarios, the infusion device is controlled such that the manual-mode basal rate setting is adjusted in accordance with the recommendation.

Claims (86)

1. A method of managing use of an insulin infusion device that is configured to operate in at least a manual insulin delivery mode or an automated closed-loop insulin delivery mode, the method comprising:

accessing closed-loop pump data for a user of the insulin infusion device, the closed-loop pump data comprising data indicating basal insulin delivered by the insulin infusion device to the user during operation in the automated closed-loop insulin delivery mode for at least one defined period of time;

analyzing the closed-loop pump data to generate updated basal rate data for the user;

generating, while operating in the automated closed-loop insulin delivery mode, a recommendation based on the updated basal rate data to adjust a manual-mode basal rate setting of the insulin infusion device, wherein the manual-mode basal rate setting is separate from automated closed-loop insulin delivery mode settings and wherein the insulin infusion device implements the manual-mode basal rate setting during operation in the manual insulin delivery mode; and

controlling the insulin infusion device, while operating in the automated closed-loop insulin delivery mode, to adjust the manual-mode basal rate setting in accordance with the recommendation.

2. The method of claim 1 , wherein:

the receiving, the analyzing, and the generating are performed by a computing device in data communication with the insulin infusion device; and

the method further comprises communicating the recommendation from the computing device to the insulin infusion device.

3. The method of claim 2 , wherein the controlling is automatically performed by the insulin infusion device in response to receiving the recommendation from the computing device.

4. The method of claim 1 , further comprising controlling operation of the insulin infusion device in the manual insulin delivery mode, in accordance with the manual-mode basal rate setting as adjusted.

5. The method of claim 1 , further comprising accessing closed-loop pump data for a second user of a second insulin infusion device, wherein the analyzing analyzes the closed-loop pump data for the user and the closed-loop pump data for the second user to generate the updated basal rate data for the user.

6. The method of claim 1 , wherein:

the receiving, the analyzing, and the generating are performed by the insulin infusion device; and

the controlling is automatically performed by the insulin infusion device in response to the recommendation being generated.

7. The method of claim 1 ,

wherein the manual-mode basal rate setting comprises a basal rate profile that defines a plurality of manual-mode basal rates corresponding to a plurality of time segments covering an entirety of a 24-hour day; and

wherein the controlling includes controlling the insulin infusion device to adjust the plurality of manual-mode basal rates in accordance with the recommendation for each time segment of the plurality of time segments by:

determining, based on the closed-loop pump data, a percentage of average daily closed-loop basal insulin delivered during the respective time segment, and

adjusting the manual-mode basal rate corresponding to the respective time segment based on the percentage of average daily closed-loop basal insulin delivered for the respective time segment.

8. The method of claim 1 , wherein:

the manual-mode basal rate setting comprises a basal rate value for a 24-hour period; and

the basal rate value is adjusted in accordance with the recommendation during the controlling.

9. The method of claim 1 , wherein:

the closed-loop pump data comprises data indicating an average total daily dose (TDD) of insulin for the user;

the method further comprising updating an insulin sensitivity factor (ISF) of the user in accordance with the expression

ISF

=

X

Average

TDD

;

ISF is expressed in units of mg/dL/Unit;

X is express in units of mg/dL/day and relates to an insulin regimen of the insulin infusion device; and

Average TDD is expressed in units of Units/day.

10. The method of claim 9 , further comprising controlling the insulin infusion device to utilize the updated insulin sensitivity factor during operation in the manual insulin delivery mode.

11. A computing device comprising:

at least one processor; and

a memory operatively coupled with the at least one processor, the memory storing executable instructions which, when executed by the at least one processor, cause the computing device to perform a method comprising:

accessing closed-loop pump data for a user of an insulin infusion device that operates in at least a manual insulin delivery mode or an automated closed-loop insulin delivery mode, the closed-loop pump data comprising data indicating basal insulin delivered by the insulin infusion device to the user during operation in the automated closed-loop insulin delivery mode for at least one defined period of time;

analyzing the closed-loop pump data to generate updated basal rate data for the user;

generating, while the insulin infusion device operates in the automated closed-loop insulin delivery mode, a recommendation based on the updated basal rate data to adjust a manual-mode basal rate setting of the insulin infusion device, wherein the manual-mode basal rate setting is separate from automated closed-loop insulin delivery mode settings and wherein the insulin infusion device implements the manual-mode basal rate setting during operation in the manual insulin delivery mode; and

communicating the recommendation from the computing device to the insulin infusion device while the insulin infusion device operates in the automated closed-loop insulin delivery mode.

12. The computing device of claim 11 , wherein the recommendation causes the insulin infusion device to automatically adjust the manual-mode basal rate setting.

13. The computing device of claim 11 , wherein the executable instructions, when executed by the at least one processor, cause the computing device to perform the method further comprising controlling operation of the insulin infusion device in the manual insulin delivery mode, in accordance with the manual-mode basal rate setting.

14. The computing device of claim 11 , wherein the executable instructions, when executed by the at least one processor, cause the computing device to perform the method further comprising accessing closed-loop pump data for a second user of a second insulin infusion device, wherein the analyzing analyzes the closed-loop pump data for the user and the closed-loop pump data for the second user to generate the updated basal rate data for the user.

15. The computing device of claim 11 , wherein:

the closed-loop pump data comprises data indicating an average total daily dose (TDD) of insulin for the user;

the executable instructions, when executed by the at least one processor, cause the computing device to perform the method further comprising updating an insulin sensitivity factor (ISF) of the user in accordance with the expression

ISF

=

X

Average

TDD

;

ISF is expressed in units of mg/dL/Unit;

Xis express in units of mg/dL/day and relates to an insulin regimen of the insulin infusion device; and

Average TDD is expressed in units of Units/day.

16. The computing device of claim 15 , wherein the executable instructions, when executed by the at least one processor, cause the computing device to perform the method further comprising controlling the insulin infusion device to utilize the updated insulin sensitivity factor during operation in the manual insulin delivery mode.

17. An insulin infusion and management system comprising:

an insulin infusion device configured to operate in at least a manual insulin delivery mode or an automated closed-loop insulin delivery mode to delivery insulin to a user; and

a computing device that supports data communication with the insulin infusion device, the computing device comprising at least one processor and a memory operatively coupled with the at least one processor, the memory storing executable instructions which, when executed by the at least one processor cause the computing device to perform a method comprising:

accessing, with the computing device, closed-loop pump data for the user of the insulin infusion device, the closed-loop pump data comprising data indicating basal insulin delivered by the insulin infusion device to the user during operation in the automated closed-loop insulin delivery mode for at least one defined period of time;

analyzing, with the computing device, the received closed-loop pump data to generate updated basal rate data for the user;

generating, while the insulin infusion device operates in the automated closed-loop insulin delivery mode, a recommendation based on the updated basal rate data to adjust a manual-mode basal rate setting of the insulin infusion device, wherein the manual-mode basal rate setting is separate from automated closed-loop insulin delivery mode settings and wherein the insulin infusion device implements the manual-mode basal rate setting during operation in the manual insulin delivery mode, and wherein the generating is performed by the computing device; and

communicating the recommendation from the computing device to the insulin infusion device while the insulin infusion device operates in the automated closed-loop insulin delivery mode.

18. The system of claim 17 , wherein the insulin infusion device automatically adjusts the manual-mode basal rate setting in response to receiving the recommendation from the computing device.

19. The system of claim 17 , wherein the executable instructions, when executed by the at least one processor, cause the computing device to perform the method further comprising accessing closed-loop pump data for a second user of a second insulin infusion device, wherein the analyzing analyzes the received closed-loop pump data for the user and the closed-loop pump data for the second user to generate the updated basal rate data for the user.

20. The system of claim 17 , wherein:

the closed-loop pump data comprises data indicating an average total daily dose (TDD) of insulin for the user;

wherein the executable instructions, when executed by the at least one processor, cause the computing device to perform the method further comprising updating an insulin sensitivity factor (ISF) of the user in accordance with the expression

ISF

=

X

Average

TDD

;

ISF is expressed in units of mg/dL/Unit;

X is express in units of mg/dL/day and relates to an insulin regimen of the insulin infusion device; and

Average TDD is expressed in units of Units/day.

21. The system of claim 20 , wherein the executable instructions, when executed by the at least one processor, cause the computing device to perform the method further comprising controlling the insulin infusion device to utilize the updated insulin sensitivity factor during operation in the manual insulin delivery mode.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2019
From: PARIKH, NEHA J.; ROY, ANIRBAN; GROSMAN, BENYAMIN; WEYDT, PATRICK E.; LINTEREUR, LOUIS J.; WU, DI; KAUFMAN, FRANCINE R.; LEE, SCOTT W.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 047961/0257 →